CompletedInterventionalPhase 4Updated Nov 19, 2008
Cosopt Versus Xalacom | NCT00273481 | Trialant
CompletedInterventionalPhase 4Updated Nov 19, 2008
Cosopt Versus Xalacom
ClinicalTrials.gov ID
NCT00273481
Lead Sponsor
Pharmaceutical Research NetworkOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
33
Last Update Posted
Nov 19, 2008Estimated
Start Date
Sep 2005
Completion Date
Apr 2007Actual
Brief Summary
To compare the intraocular pressure efficacy and safety of the DTFC given twice daily versus the LTFC given once every morning following a run-in period with timolol maleate given twice daily.